Frontiers | Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors
Team | IMMEI
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
Krebszentrum CIO Bonn - Ich bin Prof. Annkristin Heine | Facebook
Pacritinib protects dendritic cells more efficiently than ruxolitinib - Experimental Hematology
UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports
Cardiac MRI Depicts Immune Checkpoint Inhibitor–induced Myocarditis: A Prospective Study
Ann-Kristin Müller – Stellvertretende Niederlassungsleiterin – Heine + Beisswenger Gruppe | LinkedIn
Frontiers | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation
CIO Bonn - Tumorboards
CIO Bonn - Lymphomzentrum
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
UKB NewsRoom | Annkristin Heine
Medicine®
Tückischen Blutkrebs effektiv bekämpfen - Centrum für Integrierte Onkologie
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function
Unter der Leitung von Frau Prof.... - Krebszentrum CIO Bonn | Facebook
Researchers release the brakes on the immune | EurekAlert!
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Cardiac MRI in Suspected Acute COVID-19 Myocarditis
Bjørn Heine Strand - NIPH
